μ-opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer

Anesthesiology

Volumn 116, Issue 4, 2012, Pages 896-902

  Bortsov, Andrey V ^a   Millikan, Robert C ^b   Belfer, Inna ^d   Boortz Marx, Richard L ^c   Arora, Harendra ^c   McLean, Samuel A ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MU OPIATE RECEPTOR;

A118G GENE; ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAZARD RATIO; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MORTALITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RECEPTORS, OPIOID, MU; SURVIVAL RATE; YOUNG ADULT;

EID: 84859077430     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31824b96a1     Document Type: Article

References (43)

1. Waldhoer M, Bartlett SE, Whistler JL: Opioid receptors. Annu Rev Biochem 2004; 73:953-90 (Pubitemid 39050391)
2. Afsharimani B, Cabot P, Parat MO: Morphine and tumor growth and metastasis. Cancer Metastasis Rev 2011; 30: 225-38
3. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K: COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 2007; 97:1523-31 (Pubitemid 350175846)
4. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, Hebbel RP: Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002; 62:4491-8 (Pubitemid 34827313)
5. Poonawala T, Levay-Young BK, Hebbel RP, Gupta K: Opioids heal ischemic wounds in the rat. Wound Repair Regen 2005; 13:165-74 (Pubitemid 40489866)
6. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J: Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res 2006; 72:3-11 (Pubitemid 44118390)
7. Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, Kirchner VA, Koodie L, Ma J, Meng J, Barke RA: Opioid drug abuse and modulation of immune function: Consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol 2011; 6:442-65
8. Roy S, Wang J, Kelschenbach J, Koodie L, Martin J: Modulation of immune function by morphine: Implications for susceptibility to infection. J Neuroimmune Pharmacol 2006; 1:77-89 (Pubitemid 44257502)
9. Roy S, Barke RA, Loh HH: μ-opioid receptor-knockout mice: Role of μ-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 1998; 61:190-4 (Pubitemid 28511362)
10. Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, Rogers TJ: Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 1993; 267:703-6 (Pubitemid 23352527)
11. Wang J, Barke RA, Ma J, Charboneau R, Roy S: Opiate abuse, innate immunity, and bacterial infectious diseases. Arch Immunol Ther Exp (Warsz) 2008; 56:299-309
12. Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ: Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. Neuropsychopharmacology 2006; 31:2313-7 (Pubitemid 44413212)
13. Ben-Eliyahu S: The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 2003; 17(Suppl 1): S27-36
14. Dietrich K, Schned A, Fortuny J, Heaney J, Marsit C, Kelsey KT, Karagas MR: Glucocorticoid therapy and risk of bladder cancer. Br J Cancer 2009; 101:1316-20
15. Mathew B, Lennon FE, Siegler J, Mirzapoiazova T, Mambetsariev N, Sammani S, Gerhold LM, LaRiviere PJ, Chen CT, Garcia JG, Salgia R, Moss J, Singleton PA: The novel role of the μ opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg 2011; 112:558-67
16. Boehncke S, Hardt K, Schadendorf D, Henschler R, Boehncke WH, Duthey B: Endogenous μ-opioid peptides modulate immune response towards malignant melanoma. Exp Dermatol 2011; 20:24-8
17. Cata JP, Gottumukkala V, Sessler DI: How regional analgesia might reduce postoperative cancer recurrence. Eur J Pain Suppl 2011; 5:345-55
18. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L: Expansion of the human μ-opioid receptor gene architecture: Novel functional variants. Hum Mol Genet 2009; 18:1037-51
19. Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W: Allelic expression imbalance of human μ opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280:32618-24 (Pubitemid 41368304)
20. Fukuda K, Hayashida M, Ide S, Saita N, Kokita Y, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Nagashima M, Tagami M, Komatsu H, Sora I, Koga H, Kaneko Y, Ikeda K: Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain 2009; 147:194-201
21. Hayashida M, Nagashima M, Satoh Y, Katoh R, Tagami M, Ide S, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Komatsu H, Sora I, Fukuda K, Koga H, Hanaoka K, Ikeda K: Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 2008; 9:1605-16
22. Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH, Lee TH, Concejero A, Hsu CJ: Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 2006; 50:787-92 (Pubitemid 44034227)
23. Reyes-Gibby CC, Shete S, Rakvåg T, Bhat SV, Skorpen F, Bruera E, Kaasa S, Klepstad P: Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 2007; 130:25-30 (Pubitemid 46850782)
24. O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, Dressler LG, Geradts J, Millikan RC: Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010; 16:6100-10
25. Rogot E, Sorlie P, Johnson NJ: Probabilistic methods in matching census samples to the National Death Index. J Chronic Dis 1986; 39:719-34 (Pubitemid 16046321)
26. Rich-Edwards JW, Corsano KA, Stampfer MJ: Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994; 140:1016-9 (Pubitemid 24373006)
27. Salanti G, Amountza G, Ntzani EE, Ioannidis JP: Hardy-Weinberg equilibrium in genetic association studies: An empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005; 13:840-8 (Pubitemid 40946083)
28. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5 (Pubitemid 40202029)
29. Kleinbaum DG, Klein M: Survival Analysis: A Self-Learning Text, 2nd Edition. New York: Springer Verlag; 2005:131-71
30. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, CatalàE, Bryce DA, Coyne PJ, Pool GE, Implantable Drug Delivery Systems Study Group: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20:4040-9
31. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ: Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: A retrospective analysis. ANESTHESIOLOGY 2008; 109:180-7
32. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI: Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? ANESTHESIOLOGY 2006; 105:660-4 (Pubitemid 44477309)
33. Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC: Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. ANESTHESIOLOGY 2010; 113:27-34
34. Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, Finucane BT: Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010; 57:107-12
35. Holmes L Jr, Opara F, Hossain J: A five-year breast cancer-specific survival disadvantage of African American women. Afr J Reprod Health 2010; 14:195-200
36. Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS: Regional and racial disparities in breast cancer-specific mortality. Soc Sci Med 2006; 62:337-47 (Pubitemid 41735422)
37. Lee HJ, Lee JH, Lee EO, Kim KH, Lee KS, Lee CH, Nam DW, Kim SH, Lee HJ, Ahn KS: Substance P and beta endorphin mediate electroacupuncture induced analgesic activity in mouse cancer pain model. Acupunct Electrother Res 2009; 34:27-40
38. Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C: Human μ opioid receptor (OPRM1 A118G) polymorphism is associated with brain μ-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A 2011; 108:9268-73
39. Hernandez-Avila CA, Covault J, Wand G, Zhang H, Gelernter J, Kranzler HR: Population-specific effects of the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) on HPA-axis activation. Pharmacogenet Genomics 2007; 17: 1031-8 (Pubitemid 351339487)
40. Maynard C, Lowy E, McDonell M, Fihn SD: Cause of death in Washington state veterans hospitalized with acute coronary syndromes in the veterans health administration. Popul Health Metr 2008; 6:3
41. Singleton PA, Moss J: Effect of perioperative opioids on cancer recurrence: A hypothesis. Future Oncol 2010; 6:1237-42
42. Durieux ME: Does anesthetic management affect cancer outcome. APSF Newsl 2009; 23:49-51
43. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 2002; 296:2225-9 (Pubitemid 34680308)